Literature DB >> 27297910

Effectiveness of golimumab in inducing remission and clinical response in outpatient ulcerative colitis.

Antonio Tursi1, Leonardo Allegretta2, Nicola Della Valle3, Yusef Hadad4, Antonio Penna5, Giuseppe Pranzo6, Cristina Ricciardelli7, Primaldo Paiano7, Marcello Picchio8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27297910     DOI： 10.1016/j.clinre.2016.05.003

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  5 in total

1.  Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.

Authors:  Iris Detrez; Ganel Schops; Jolien Lefrère; Sophie Tops; Gert Van Assche; Séverine Vermeire; Wouter Van Moerkercke; Marc Ferrante; Ann Gils
Journal:  AAPS J       Date:  2018-12-18       Impact factor: 4.009

2.  Golimumab for ulcerative colitis: adding perspective to the pursuit.

Authors:  Jimmy K Limdi
Journal:  Frontline Gastroenterol       Date:  2017-11-29

3.  Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.

Authors:  Kathrin Perrig; Niklas Krupka; Sebastian Bruno Ulrich Jordi; Jean-Benoît Rossel; Luc Biedermann; Thomas Greuter; Philipp Schreiner; Stephan R Vavricka; Pascal Juillerat; Emanuel Burri; Dorothee Zimmermann; Michel H Maillard; Michael Christian Sulz; Stephan Brand; Gerhard Rogler; Benjamin Misselwitz
Journal:  Therap Adv Gastroenterol       Date:  2022-02-09       Impact factor: 4.409

4.  Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study.

Authors:  Jongwook Yu; Soo Jung Park; Hyung Wook Kim; Yun Jeong Lim; Jihye Park; Jae Myung Cha; Byong Duk Ye; Tae Oh Kim; Hyun-Soo Kim; Hyun Seok Lee; Su Young Jung; Youngdoe Kim; Chang Hwan Choi
Journal:  Gut Liver       Date:  2021-12-27       Impact factor: 4.321

5.  Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres.

Authors:  Mark A Samaan; Polychronis Pavlidis; Jonathan Digby-Bell; Emma L Johnston; Angad Dhillon; Ramesh Paramsothy; Abisoye O Akintimehin; Lucy Medcalf; Guy Chung-Faye; Patrick DuBois; Ioannis Koumoutsos; Nick Powell; Simon H C Anderson; Jeremy Sanderson; Bu' Hussain Hayee; Peter M Irving
Journal:  Frontline Gastroenterol       Date:  2017-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.